Phosphatidylinositol 3-Kinases

Displaying 1 - 5 of 5CSV
Shin, A. E., Sugiura, K., Kariuki, S. W., Cohen, D. A., Flashner, S. P., Klein-Szanto, A. J., Nishiwaki, N., De, D., Vasan, N., Gabre, J. T., Lengner, C. J., Sims, P. A., & Rustgi, A. K. (2025). LIN28B-mediated PI3K/AKT pathway activation promotes metastasis in colorectal cancer models. Journal of Clinical Investigation. https://doi.org/10.1172/jci186035
Publication Date
Wang, P. H., Washburn, R. S., Mariuzza, D. L., Lin, W.-H. W., Gill, A. L., Ahmed, R., & Reiner, S. L. (2023). Reciprocal transmission of activating and inhibitory signals and cell fate in regenerating T cells. Cell Reports, 42(10), 113155. https://doi.org/10.1016/j.celrep.2023.113155
Publication Date
Sivakumar, S., Jin, D. X., Rathod, R., Ross, J., Cantley, L. C., Scaltriti, M., Chen, J. W., Hutchinson, K. E., Wilson, T. R., Sokol, E. S., & Vasan, N. (2023). Genetic Heterogeneity and Tissue-specific Patterns of Tumors with MultiplePIK3CAMutations. Clinical Cancer Research, 29(6), 1125–1136. https://doi.org/10.1158/1078-0432.ccr-22-2270
Publication Date
Debelenko, L., Mansukhani, M. M., & Remotti, F. (2023). Papillary Intralymphatic Angioendothelioma in a Child With PIK3CA-Related Overgrowth Spectrum: Implication of PI3K Pathway in the Vascular Tumorigenesis. Pediatric and Developmental Pathology, 26(2), 166–171. https://doi.org/10.1177/10935266231152370
Publication Date
Oh, J., Garabedian, E., Fuleihan, R., & Cunningham-Rundles, C. (2021). Clinical Manifestations and Outcomes of Activated Phosphoinositide 3-Kinase δ Syndrome from the USIDNET Cohort. The Journal of Allergy and Clinical Immunology: In Practice, 9(11), 4095–4102. https://doi.org/10.1016/j.jaip.2021.07.044
Publication Date